Cedars Sinai 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2024

Cedars Sinai 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2024

Format: 2 videos + 10 pdfs, size: 3.88 GB

Course Audience: Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine physician

Overview:

Date & Location

Saturday, March 23, 2024, 7:30 AM – 12:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA

Target Audience

Specialties – Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology & Laboratory Medicine, Radiation Oncology, Radiology

Professions – Nurse (Advanced Practice NP CRNA CNM CNS), Other (non-physician), Physician

 

Overview

The 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.

Objectives

1. Consider advances in biomarkers and therapy to better inform treatment decision-making for patients with gastroesophageal cancers
2. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
3. Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
4. Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies
5. Identify and implement optimal strategies for managing therapy-related side effects and toxicities in patients treated with therapeutic agents
6. Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

 

 

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Agenda (PDF Format)

Cedars Sinai Cancer- Molecular Twin (PDF Format)

Cholangiocarcinoma and HCC (PDF Format)

How I approach TNT in Rectal Cancer (PDF Format)

Immunotherapy for GI Cancer (PDF Format)

Managment updates in Neuroendocrine tumors 2024 (PDF Format)

March 23 Part 1 (Video MP4 Format)

March 23 Part 2 (Video MP4 Format)

Molecular Landscape in CRC- Shaping the Future (PDF Format)

Role of Social Media in Oncology Today (PDF Format)

The Challenges of Treating Pancreatic Cancer (PDF Format)

Update in Surgical Management of Gastric Cancer (PDF Format)

 

*Detail:

Saturday, March 23, 2024

Introduction

8:00AM – 8:05AM

Andrew E Hendifar, MD

Arsen Osipov, MD

Jun Gong, MD

Molecular Landscape in CRC: Shaping the Future

8:05AM – 8:25AM

Marwan Fakih, MD

The Challenges of Treating Pancreatic Cancer

8:25AM – 8:45AM

Philip Philip, MD

Cholangiocarcinoma and HCC

8:45AM – 9:05AM

Anthony El-Khoueiry, MD

Update in Surgical Management of Gastric Cancer

9:05AM – 9:25AM

Miguel Burch, MD

Panel Discussion: GI Cancer Cases

9:25AM – 9:45AM

Anthony El-Khoueiry, MD

Edward Wolin, MD

Philip Philip, MD

Emily Nachtigal, MD (Panelist)

Vi K. Chiu, MD, PhD (Panelist)

Kambiz Kosari, MD

Break and Exhibits

9:45AM – 10:05AM

Novel approaches to targeting amino acid metabolism and the PI3K pathway in cancer

10:05AM – 10:25AM

Oliver DK Maddocks, MPharm, PhD

Cedars Sinai Cancer: Molecular Twin

10:25AM – 10:45AM

Dan Theodorescu, MD, PhD

How I approach TNT in Rectal Cancer

10:45AM – 11:05AM

Katelyn Atkins, MD, PhD

Managment updates in Neuroendocrine tumors 2024

11:05AM – 11:25AM

Edward Wolin, MD

Pick Up Lunch and Exhibits

11:25AM – 11:45AM

Immunotherapy for GI Cancer

11:45AM – 12:05PM

Joel R Hecht, MD

Role of Social Media in Oncology Today

12:05PM – 12:25PM

Tatiana Prowell, MD

Closing Remarks

12:25PM – 12:30PM

Andrew E Hendifar, MD